−Removed: Other Information
The following documents are filed herewith:
37 unchanged sentences
333-163041, filed on November 12, 2009, as amended.
−Removed: Incorporated by reference to the registrant’s quarterly report on Form 10-Q, File no.
−Removed: filed on May 9, 2012.
Filed herewith.
11 unchanged sentences
DEHAIER MEDICAL SYSTEMS LIMITED
−Removed: August 13, 2012
+Added: November 13, 2012
/s/ Ping Chen
5 unchanged sentences
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
−Removed: Condensed Consolidated Balance Sheets as of June 30, 2012 and December 31, 2011
−Removed: Condensed Consolidated Statements of Income and Comprehensive Income for the six and three months ended June 30, 2012 and 2011
−Removed: Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2012 and 2011
+Added: Condensed Consolidated Balance Sheets as of September 30, 2012 and December 31, 2011
+Added: Condensed Consolidated Statements of Income and Comprehensive Income for the nine and three months ended September 30, 2012 and 2011
+Added: Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2012 and 2011
Notes to the Unaudited Condensed Consolidated Financial Statements
1 unchanged sentence
CONDENSED CONSOLIDATED BALANCE SHEETS
+Added: September 30,
CURRENT ASSETS:
2 unchanged sentences
-less allowance for doubtful accounts of $898,900 and $859,509
+Added: Contract Deposits
Other receivables
+Added: Advances to Suppliers
Prepayment and other current assets
18 unchanged sentences
Commitments and Contingency
−Removed: Common shares, $0.002731 par value, 18,307,038 shares authorized, 4,570,000 and 4,560,000 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively
+Added: Common shares, $0.002731 par value, 18,307,038 shares authorized,4,590,000 and 4,560,000 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively
Additional paid in capital
8 unchanged sentences
CONDENSED CONSOLIDATED STATEMENTS OF
−Removed: For the six months ended
+Added: INCOME AND COMPREHENSIVE INCOME
+Added: For the nine months ended
+Added: September 30,
For the three months ended
+Added: September 30,
Costs of revenue
+Added: (10,098,506 )
Service income
3 unchanged sentences
Operating Income
−Removed: Financial expenses (including interest expense of $64,904, $26,993, $37,741 and $10,816 for the six and three months ended June 30, 2012 and 2011, respectively)
+Added: Financial expenses (including interest expense of $107,965, $53,915, $43,061 and $26,922 for the nine and three months ended September 30, 2012 and 2011, respectively)
Non-operating Income
15 unchanged sentences
CONDENSED CONSOLIDATED STATEMENTS OF
−Removed: For the six months ended
+Added: For the nine months ended
+Added: September 30,
Cash flows from operating activities
−Removed: Adjustments to reconcile net income to net cash used in operating activities
+Added: Adjustments to reconcile net income to net cash (used in) provided by operating activities
Stock-based compensation expense
1 unchanged sentence
Change in fair value of warrants liability
−Removed: Recovery of doubtful accounts
+Added: Provision for doubtful accounts
Changes in assets and liabilities:
1 unchanged sentence
Increase in prepayments and other current assets
−Removed: Decrease (Increase) in other receivables
+Added: Increase in other receivables
Decrease (Increase) in inventories
Decrease (Increase) in tax receivable
−Removed: Increase (Decrease) in accounts payable
−Removed: Decrease in advances from customers
−Removed: (Decrease) Increase in accrued expenses and other current liabilities
−Removed: (Decrease) Increase in tax payable
−Removed: Net cash used in operating activities
+Added: Decrease in accounts payable
+Added: Increase (Decrease) in advances from customers
+Added: Increase (Decrease) in accrued expenses and other current liabilities
+Added: Increase (Decrease) in tax payable
+Added: Net cash (used in) provided by operating activities
Cash flows from investing activities
13 unchanged sentences
Interest paid
+Added: Issuance of common shares for investment relation activities
The accompanying notes are an integral
28 unchanged sentences
the condensed consolidated financial position, results of operations and cash flows of the Company for the periods presented.
−Removed: results of operations for the six and three months ended June 30, 2012 are not necessarily indicative of operating results expected
−Removed: for the full year or future interim periods.
−Removed: These unaudited condensed consolidated financial statements should be read in conjunction
−Removed: with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year
−Removed: ended December 31, 2011, filed on March 19, 2012.
+Added: results of operations for the nine and three months ended September 30, 2012 are not necessarily indicative of operating results
+Added: expected for the full year or future interim periods.
+Added: These unaudited condensed consolidated financial statements should be read
+Added: in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K
+Added: for the year ended December 31, 2011, filed on March 19, 2012.
Basis of Consolidation
22 unchanged sentences
of BTL’s assets and liabilities included in the Condensed Consolidated Balance Sheets are as follows:
+Added: September 30,
Total current assets
8 unchanged sentences
Use of Estimates
−Removed: The preparation of the condensed consolidated
−Removed: financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
−Removed: and disclosure of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported
−Removed: amounts of revenues and expenses during the reporting periods.
−Removed: Estimates are adjusted to reflect actual experience when necessary.
−Removed: Significant accounting estimates reflected in the Company's condensed consolidated financial statements include revenue recognition,
−Removed: allowance for doubtful accounts, warranty obligation, warrants liability, Stock-based compensation and useful lives of intangible
−Removed: assets, and property and equipment.
+Added: The preparation of the unaudited condensed
+Added: consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets
+Added: and liabilities and disclosure of contingent assets and liabilities at the dates of the condensed consolidated financial statements
+Added: and the reported amounts of revenues and expenses during the reporting periods.
+Added: Estimates are adjusted to reflect actual experience
+Added: when necessary.
+Added: Significant accounting estimates reflected in the Company's unaudited condensed consolidated financial statements
+Added: include revenue recognition, allowance for doubtful accounts, warranty obligation, warrants liability, Stock-based compensation
+Added: and useful lives of intangible assets, and property and equipment.
Actual results could differ from those estimates.
13 unchanged sentences
Management has determined that an allowance of $898,900 (RMB5,650,224) and $859,509 (RMB5,419,725)
−Removed: was appropriate at June 30, 2012 and December 31, 2011 respectively.
+Added: was appropriate at September 30, 2012 and December 31, 2011 respectively.
Advances to Suppliers and Advances from
1 unchanged sentence
in the PRC, often makes advance payments to suppliers for unassembled parts, or receives advance payments from customers.
−Removed: to suppliers were $4,754,727 and $4,348,847 as of June 30, 2012 and December 31, 2011, respectively, which were included in prepayments
−Removed: and other current assets.
−Removed: Advances from customers were $237,653 and $303,000 as of June 30, 2012 and December 31, 2011, respectively.
+Added: to suppliers were $5,196,015 and $4,348,847 as of September 30, 2012 and December 31, 2011.
+Added: Advances from customers were $201,883
+Added: and $303,000 as of September 30, 2012 and December 31, 2011, respectively.
DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
16 unchanged sentences
The fair value of the warrants liability is measured each reporting
−Removed: period with the resulting change in fair value recorded in the condensed consolidated statement of income and comprehensive income
−Removed: (see Note 12).
+Added: period with the resulting change in fair value recorded in the unaudited condensed consolidated statement of income and comprehensive
+Added: income (see Note 12).
The accounting standards regarding fair
19 unchanged sentences
The reserve for obsolescence was $51,316 (RMB322,556)
−Removed: and $51,154 (RMB322,556) as of June 30, 2012 and December 31, 2011, respectively, and the provision is included in the operating
−Removed: expenses in the condensed consolidated statements of operations.
+Added: and $51,154 (RMB322,556) as of September 30, 2012 and December 31, 2011, respectively, and the provision is included in the operating
+Added: expenses in the unaudited condensed consolidated statements of operations.
DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
86 unchanged sentences
The reserve for warranty costs was $335,739 (RMB2,110,361),
−Removed: $334,680 (RMB2,110,361) at June 30, 2012 and December 31, 2011, respectively.
−Removed: Warranty expense for the six and three months ended
−Removed: June 30, 2012 and 2011 was $25,081, $106,648, $16,770 and $77,121, respectively.
+Added: $334,680 (RMB2,110,361) at September 30, 2012 and December 31, 2011, respectively.
+Added: Warranty expense for the nine and three months
+Added: ended September 30, 2012 and 2011 was $38,692, $163,538, $13,611 and $56,890, respectively.
Earnings per Share
38 unchanged sentences
it is more likely than not that some portion or all of the deferred tax assets will not be realized.
−Removed: As of June 30, 2012, the Company
−Removed: recorded a deferred tax asset for the temporary differences arising from allowance for doubtful accounts and certain accrued expenses.
+Added: As of September 30, 2012,
+Added: the Company recorded a deferred tax asset for the temporary differences arising from allowance for doubtful accounts and certain
+Added: accrued expenses.
The company believes it can utilize the deferred tax asset to offset future taxable income.
−Removed: Therefore, no valuation allowance has
−Removed: been provided as of June 30, 2012 and December 31, 2011.
+Added: Therefore, no valuation
+Added: allowance has been provided as of September 30, 2012 and December 31, 2011.
ASC 740-10 prescribes a recognition threshold
12 unchanged sentences
The Company had filed its 2008 and 2009 Value
−Removed: Added Tax (“VAT”) returns for some of its customers during the year 2011 and six months ended June 30, 2012.
−Removed: potential VAT liabilities on these VAT returns occurred in current period were also accrued and included in the accompanying condensed
−Removed: consolidated financial statements.
+Added: Added Tax (“VAT”) returns for some of its customers during the year 2011 and nine months ended September 30, 2012.
+Added: All the potential VAT liabilities on these VAT returns occurred in current period were also accrued and included in the accompanying
+Added: condensed consolidated financial statements.
The implementation of ASC 740-10 resulted
in no material liability for unrecognized tax benefits.
−Removed: As of June 30, 2012 and December 31, 2011, the Company did not have a liability
−Removed: for any unrecognized tax benefits.
−Removed: The Company recognizes interest and penalties, if any, related to unrecognized tax benefits
−Removed: as income tax expense in the statement of operations.
−Removed: During the six months ended June 30, 2012 and 2011, the Company did not incur
−Removed: any interest or penalties.
+Added: As of September 30, 2012 and December 31, 2011, the Company did not have
+Added: a liability for any unrecognized tax benefits.
+Added: The Company recognizes interest and penalties, if any, related to unrecognized tax
+Added: benefits as income tax expense in the statement of operations.
+Added: During the nine months ended September 30, 2012 and 2011, the Company
+Added: did not incur any interest or penalties.
Income tax returns for the year prior to
2009 are no longer subject to examination by tax authorities.
−Removed: DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
+Added: MEDICAL SYSTEMS LIMITED AND AFFILIATE
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED
2 unchanged sentences
Other receivables consist of the following:
+Added: September 30,
Due from suppliers
−Removed: Deposits for ongoing contracts
Employee advances
1 unchanged sentence
and other current assets consist of the following:
−Removed: Advances to suppliers
+Added: September 30,
Prepayment for equipment purchase
2 unchanged sentences
Property and equipment consist of the following:
+Added: September 30,
Land use rights
6 unchanged sentences
Depreciation and amortization expense was
−Removed: $246,448, $219,976, $127,724 and $110,603 for the six and three months ended June 30, 2012 and 2011 ,
+Added: $399,135, $333,580, $152,687 and $113,604 for the nine and three months ended September 30, 2012 and 2011 ,
respectively.
−Removed: MEDICAL SYSTEMS LIMITED AND AFFILIATE
+Added: DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED
7 unchanged sentences
INTANGIBLE ASSETS, NET
+Added: September 30,
Software Copyright
2 unchanged sentences
Approximate future minimum amortizations
−Removed: at June 30, for the next five years are 127,204 annually.
+Added: at September 30, for the next five years are 265,043 annually.
TAX RECEIVABLE
Tax receivable consists of the following:
+Added: September 30,
Value added tax receivable
4 unchanged sentences
of the Company’s product used in contract and production can be used to offset the VAT due on sales of the product.
−Removed: The tax receivable as of June 30, 2012
+Added: The tax receivable as of September 30,
2012 and December 31, 2011 represents VAT credit on the purchased products.
−Removed: These amounts can be used to offset the VAT due on sales
−Removed: of the finished product.
+Added: These amounts can be used to offset the VAT due on
+Added: sales of the finished product.
SHORT-TERM BORROWINGS
−Removed: The Company has a line of credit for RMB10,000,000
−Removed: with a commercial bank in China to finance its working capital.
−Removed: The credit line bears interest at a variable rate and is renewed
−Removed: annually on May 14th.
−Removed: Average interest rates for the six months ended June 30, 2012 and 2011 were 7.22% and 5.84%, respectively.
−Removed: Pursuant to the terms of the agreement, the line of credit is secured by BTL’s building (see note 5) and guaranteed by BDL
−Removed: and an officer of the Company.
+Added: The Company has a line of credit for $1,590,915
+Added: (RMB10,000,000) with a commercial bank in China to finance its working capital.
+Added: The credit line bears interest at a variable rate
+Added: and is renewed annually on May 14th.
+Added: Average interest rates for the nine months ended September 30, 2012 and 2011 were 7.22% and
+Added: 6.94%, respectively.
+Added: Pursuant to the terms of the agreement, the line of credit is secured by BTL’s building (see note 5)
+Added: and guaranteed by BDL and an officer of the Company.
On May 14, 2012, the bank renewed the Company's
12 unchanged sentences
Non-controlling interest consists of the following:
+Added: September 30,
Original paid-in capital
6 unchanged sentences
through December 2012 for one year.
−Removed: Approximate future minimum lease payments under these leases at June 30, 2012, are $50,000
−Removed: for the twelve months ending June 30, 2013.
−Removed: Rent expense for the six and three months
−Removed: ended June 30, 2012 and 2011 was $43,467, $72,155, $21,989 and $54,876, respectively.
+Added: Approximate future minimum lease payments under these leases at September 30, 2012, are $84,000
+Added: for the twelve months ending September 30, 2013.
+Added: Rent expense for the nine and three months
+Added: ended September 30, 2012 and 2011 was $64,641, $131,229, $21,174 and $59,074, respectively.
Employment Contracts
7 unchanged sentences
The Company has estimated its possible severance payments
−Removed: of approximately $270,000 and $235,000 as of June 30, 2012 and December 31, 2011, respectively, which have not been reflected in
−Removed: its condensed consolidated financial statements, because it is more likely than not that this will not be paid or incurred.
+Added: of approximately $295,000 and $235,000 as of September 30, 2012 and December 31, 2011, respectively, which have not been reflected
+Added: in its condensed consolidated financial statements, because it is more likely than not that this will not be paid or incurred.
DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
17 unchanged sentences
closing price was $12,000.
+Added: On August 22, 2012, Dehaier issued 20,000
+Added: restrict unregistered common shares to an independent contractor.
+Added: The fair value of the shares on the issuance date based on the
+Added: closing price was $32,000.
Statutory Surplus Reserves
15 unchanged sentences
reserve provisions will be determined by its board of directors.
−Removed: As of June 30, 2012, BDL’s board of directors has not yet
−Removed: made such determination.
+Added: As of September 30, 2012, BDL’s board of directors has not
+Added: yet made such determination.
Therefore, no amount was allocated to the statutory surplus reserve account.
1 unchanged sentence
as statutory surplus reserve, which is included as part of the non-controlling interest in the equity section.
−Removed: For the six months
−Removed: ended June 30, statutory surplus reserve activity was as follows:
−Removed: For the six months ended
−Removed: June 30, 2012
−Removed: Balance at December 31, 2011
+Added: For the nine months
+Added: ended September 30, statutory surplus reserve activity was as follows:
+Added: For the nine months
+Added: ended September 30,
+Added: For the year ended
+Added: Balance –
+Added: beginning of period
Addition to statutory reserves
−Removed: Balance at June 30, 2012
+Added: Balance –end of period
DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
9 unchanged sentences
to acquire the Company’s common shares at an exercise price of $1.45 per share.
−Removed: The options vest in equal annually installments
−Removed: over the five years of the agreements.
−Removed: As of December 29, 2011, none of the 450,000 options have been fully vested.
+Added: The options vest in equal annual installments
+Added: over the five years of the agreements beginning December 29, 2011.
The Company valued the stock options using
8 unchanged sentences
Outstanding as of December 31, 2011
−Removed: Outstanding as of June 30, 2012
+Added: Outstanding as of September 30, 2012
Following is a summary of the status of options
−Removed: outstanding and exercisable at June 30, 2012:
+Added: outstanding and exercisable at September 30, 2012:
Outstanding options
4 unchanged sentences
contractual life
−Removed: For the six and three months ended June 30,
+Added: For the nine and three months ended September
30, 2012 and 2011, the Company recognized $82,471, $0, $27,691 and $0, respectively, as compensation expense under its stock option
8 unchanged sentences
the Company’s investor relations consultancy.
−Removed: The Company had 257,500 warrants outstanding as of June 30, 2012.
−Removed: All the warrants
−Removed: issued to “A&S”
−Removed: have the right to purchase one share of common stock for an exercise price of $10.00 per share
−Removed: with a term of 5 years.
−Removed: All the warrants granted to Hawks have the right to purchase one share of common stock for an exercise
−Removed: price of $9.60 per share with a term of 5 years.
−Removed: All the warrants granted to Firs Trust have the right to purchase one share of
−Removed: common stock for an exercise price of $4.00 per share with a term of 5 years.
+Added: The Company had 257,500 warrants outstanding as of September 30, 2012.
+Added: the warrants issued to “A&S”
+Added: have the right to purchase one share of common stock for an exercise price of $10.00
+Added: per share with a term of 5 years.
+Added: All the warrants granted to Hawks have the right to purchase one share of common stock for an
+Added: exercise price of $9.60 per share with a term of 5 years.
+Added: All the warrants granted to Firs Trust have the right to purchase one
+Added: share of common stock for an exercise price of $4.00 per share with a term of 5 years.
The fair value of the outstanding warrants
−Removed: at June 30, 2012 were calculated using the Black Scholes Model with the following assumptions:
+Added: at September 30, 2012 was calculated using the Black Scholes Model with the following assumptions:
Market price per share (USD/share)
7 unchanged sentences
within the fair value hierarchy of our financial assets and liabilities that were accounted for at fair value on a recurring basis
−Removed: as of June 30, 2012 and December 31, 2011, respectively.
+Added: as of September 30, 2012 and December 31, 2011, respectively.
Carrying Value at
−Removed: June 30, 2012
+Added: September 30, 2012
Fair Value Measurement at
−Removed: June 30, 2012
+Added: September 30, 2012
Warrants liability
1 unchanged sentence
beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 2 inputs:
+Added: September 30,
Beginning balance
7 unchanged sentences
Outstanding as of December 31, 2011
−Removed: Outstanding as of June 30, 2012
+Added: Outstanding as of September 30, 2012
DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
1 unchanged sentence
FINANCIAL STATEMENTS
+Added: WARRANTS (CONTINUED)
+Added: Exercise Price
+Added: Weighted Average
+Added: Contractual Life
+Added: Outstanding as of December 31, 2010
+Added: Outstanding as of September 30, 2011
British Virgin Islands
16 unchanged sentences
Therefore, BDL used a 15% income tax rate to calculate the income
−Removed: tax expense for the six months ended June 30, 2012 and 2011.
−Removed: The high technology certification will expire and be renewed in September
+Added: tax expense for the six months ended September 30 , 2012 and 2011 .
+Added: The Company renewed
+Added: the high technology company status to keep 15% income tax rate after September 30, 2012 and received the approval in October 2012.
+Added: The Company has not received the preferential tax rate certificate as of the filing date due to the long government procedures
for BTL is 25% in 2012 and 2011.
2 unchanged sentences
and is not subject to federal income tax.
−Removed: As of June 30, 2012, Breathcare was inactive.
+Added: As of September 30, 2012, Breathcare was inactive.
DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE
3 unchanged sentences
Major Customers
−Removed: For the six and three months ended June
+Added: For the nine and three months ended September
30, 2012, approximately 7% and 19% of the Company’s revenues was received from one customer.
−Removed: For the six and three months
−Removed: ended June 30, 2011, approximately 13% and 15% of the Company’s revenues was received from one customer.
−Removed: At June 30, 2012 and 2011, receivables
+Added: For the nine and three months
+Added: ended September 30, 2011, approximately 10% and 22% of the Company’s revenues was received from one customer.
+Added: At September 30, 2012 and 2011, receivables
from four customers were approximately 7%, 7%, 7%, 6% and 10%, 9%, 8%, 8%, respectively.
−Removed: For the six and three months ended June
−Removed: 30, 2012 and 2011, the Company’s three top selling products accounted, in the aggregate, for approximately 76%, 80%, 75%,
−Removed: and 82%, respectively, of its total net revenues.
+Added: For the nine and three months ended September
+Added: 30, 2012 and 2011, the Company’s two top selling products accounted, in the aggregate, for approximately 70%, 75%,59%, and
+Added: 87%, respectively, of its total net revenues.
The following represents the revenues by
product line, all derived from China:
−Removed: For the six months ended
+Added: For the nine months ended
+Added: September 30,
For the three months ended
+Added: September 30,
Medical Devices
1 unchanged sentence
SUBSEQUENT EVENTS
−Removed: In July 2012, the Company received approved
−Removed: SFDA registration certificate for proprietary homecare medical CPAP product of Model DHR-CPAP-C5.
−Removed: The certificate is valid until
−Removed: July 1, 2016 and allows the Company to sell the products in mainland China.
+Added: On October 16, 2012, the Company won a
+Added: government procurement contract with XinJiang Province to distribute medical equipments to Hospitals in XinJiang.
+Added: will be implemented by the end of 2012.
+Added: On October 29, 2012, the Company received
+Added: a government subsidies of RMB118,000 for the interests on short-term bank loan as High Technology Enterprise.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.